| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.8M | +334.7% |
| R&D Expense | $38.6M | +125.7% |
| SG&A Expense | $19.0M | +236.6% |
| Operating Income | -$59.1M | -122.7% |
| Interest Expense | $42K | -89.3% |
| Pre-tax Income | -$9.8M | -154.1% |
| Income Tax | -$227K | -808.0% |
| Net Income | -$9.6M | -152.8% |
| EPS (Basic) | -$0.05 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.1M | -90.2% |
| Short-term Investments | $273.0M | +259.7% |
| Current Assets | $327.8M | -44.8% |
| Total Assets | $594.4M | -3.8% |
| Current Liabilities | $20.7M | +147.8% |
| Long-term Debt | $7K | -94.6% |
| Total Liabilities | $39.1M | -33.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.8M | -33.0% |
| Capital Expenditures | $58.3M | +362.0% |
| Investing Cash Flow | -$430.0M | -383.8% |
| Financing Cash Flow | $485K | -99.9% |
| Free Cash Flow | -$92.1M | -142.1% |
| -138.5% |
| EPS (Diluted) | -$0.05 | -145.5% |
| Stockholders' Equity |
| $555.4M |
| -0.6% |